Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.

Musa, A; Khalil, E; Hailu, A; Olobo, J; Balasegaram, M; Omollo, R; Edwards, T; Rashid, J; Mbui, J; Musa, B; +28 more... Abuzaid, AA; Ahmed, O; Fadlalla, A; El-Hassan, A; Mueller, M; Mucee, G; Njoroge, S; Manduku, V; Mutuma, G; Apadet, L; Lodenyo, H; Mutea, D; Kirigi, G; Yifru, S; Mengistu, G; Hurissa, Z; Hailu, W; Weldegebreal, T; Tafes, H; Mekonnen, Y; Makonnen, E; Ndegwa, S; Sagaki, P; Kimutai, R; Kesusu, J; Owiti, R; Ellis, S; Wasunna, M; (2012) Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial. PLoS neglected tropical diseases, 6 (6). e1674. ISSN 1935-2727 DOI: https://doi.org/10.1371/journal.pntd.0001674

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pntd.0001674

Abstract

Share

Download

Filename: pntd.0001674.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar